Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nitrofurantoin 2.5mg/5ml oral liquid
0501130R0AABDBD
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 20mg/5ml oral liquid
0501130R0AAAVAV
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 22mg/5ml oral liquid
0501130R0AABGBG
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 24mg/5ml oral liquid
0501130R0AABYBY
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 2mg/5ml oral liquid
0501130R0AABCBC
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 30mg/5ml oral liquid
0501130R0AAAZAZ
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 32.5mg/5ml oral liquid
0501130R0AABUBU
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 35mg/5ml oral liquid
0501130R0AABPBP
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 40mg/5ml oral liquid
0501130R0AAAPAP
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 45mg/5ml oral liquid
0501130R0AABXBX
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 4mg/5ml oral liquid
0501130R0AABVBV
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 5.5mg/5ml oral liquid
0501130R0AABNBN
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 5mg/5ml oral liquid
0501130R0AAARAR
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 6.5mg/5ml oral liquid
0501130R0AAAWAW
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 6mg/5ml oral liquid
0501130R0AABRBR
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 7.5mg/5ml oral liquid
0501130R0AAAXAX
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 7.8mg/5ml oral liquid
0501130R0AACJCJ
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 75mg/5ml oral liquid
0501130R0AABKBK
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 7mg/5ml oral liquid
0501130R0AABBBB
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 8mg/5ml oral liquid
0501130R0AABLBL
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 9.5mg/5ml oral liquid
0501130R0AABTBT
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
|
Nitrofurantoin 9mg/5ml oral liquid
0501130R0AABABA
|
Nitrofurantoin | Nitrofurantoin | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.